Who owns AYTU BIOPHARMA INC?
- Ticker: AYTU
- CUSIP Number: 054754858
Tip: Access positions for across all investors
Analyze quarterly positions in Aytu Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aytu Biopharma stock
Who bought or sold AYTU BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 1.1M | $2.3M | 0% | Jun 2026 |
|
| Stonepine Capital Management | 913k | $2.0M | 15% | Jun 2026 |
|
| AWM Investment Company | 620k | $1.3M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 261k | $562k | 0% | Jun 2026 |
|
| Crown Advisors Management | 200k | $430k | 38% | Jun 2026 |
|
| Diadema Partners | 149k | $319k | -58% | Jun 2026 |
|
| Two Sigma Investments | 105k | $227k | -14% | Jun 2026 |
|
| Renaissance Technologies | 105k | $225k | 12% | Jun 2026 |
|
| Geode Capital Management | 94k | $201k | 1% | Jun 2026 |
|
| Citadel Advisors | 49k | $106k | 34% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 47k | $101k | 0% | Jun 2026 |
|
| Dimensional Fund Advisors | 45k | $98k | 4% | Jun 2026 |
|
| Persistent Asset Partners | 38k | $82k | -59% | Jun 2026 |
|
| Northern Trust | 28k | $60k | 46% | Jun 2026 |
|
| Bellevue Asset Management | 25k | $54k | 0% | Jun 2026 |
|
| BlackRock | 23k | $49k | 0% | Jun 2026 |
|
| XTX Topco | 21k | $46k | -1% | Jun 2026 |
|
| Acadian Asset Management | 10k | $22k | 0% | Jun 2026 |
|
| Daytona Street Capital | 10k | $22k | 0% | Jun 2026 |
|
| UBS Group | 2.4k | $5.1k | 43% | Jun 2026 |
|
| Tower Research Capital | 2.2k | $4.8k | 43% | Jun 2026 |
|
| Advisor Group Holdings | 462.00 | $990.990000 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 378.00 | $999.999000 | 950% | Jun 2026 |
|
| Jpmorgan Chase & Co | 154.00 | $336.998200 | 100% | Jun 2026 |
|
| Wells Fargo & Company | 127.00 | $275.170900 | 0% | Jun 2026 |
|
| Morgan Stanley | 125.00 | $341.000000 | 0% | Mar 2026 |
|
| FNY Investment Advisers | 110.00 | $0 | 22% | Jun 2026 |
|
| Barclays | 50.00 | $108.000000 | 100% | Jun 2026 |
|
| Group One Trading | 37.00 | $80.001400 | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 23.00 | $48.999200 | 0% | Jun 2026 |
|
| Rockefeller Capital Management | 10.00 | $22.000000 | 0% | Jun 2026 |
|
| SBI Securities | 10.00 | $22.000000 | -9% | Jun 2026 |
|
| Farther Finance Advisors | 4.00 | $9.000000 | 100% | Jun 2026 |
|
| Vision Financial Markets | 2.00 | $5.000000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 2.00 | $4.000000 | 0% | Jun 2026 |
|
| SRS Capital Advisors | 2.00 | $4.000000 | 100% | Jun 2026 |
|
| TSFG | 1.00 | $0 | 0% | Jun 2026 |
|
| Jones Financial Companies, L.L | 1.00 | $2.000000 | 0% | Jun 2026 |
|
Who sold out of Aytu Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| MAI Wealth Advisors | Mar 2026 | 3.6k | $9.8k |
| Goss Wealth Management | Mar 2026 | 21.00 | $57.000300 |